Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma
Authors:
- Lulu HeLHLulu He
- Jiaxian ChenJCJiaxian Chen
- Feng XuFXFeng Xu
- Jun LiJun Li
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 19, 265-277
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81830073)
This publication has 33 references indexed in Scilit:
- The Molecular Mechanism of Metabolic Remodeling in Lung CancerJournal of Cancer, 2020
- Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancerAging, 2019
- The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose MetabolismFrontiers in Oncology, 2019
- Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinomaJournal of Translational Medicine, 2019
- Identification of a novel cell cycle‐related gene signature predicting survival in patients with gastric cancerJournal of Cellular Physiology, 2018
- Phenotype molding of stromal cells in the lung tumor microenvironmentNature Medicine, 2018
- Understanding the Intersections between Metabolism and Cancer BiologyCell, 2017
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor GenesScience, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009